These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28895423)

  • 1. Distribution of the most common polymorphisms in TYMS gene in Slavic population of central Europe.
    Pastorakova A; Chandogova D; Chandoga J; Luha J; Bohmer D; Malova J; Braxatorisova T; Juhosova M; Reznakova S; Petrovic R
    Neoplasma; 2017; 64(6):962-970. PubMed ID: 28895423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase pharmacogenetics.
    Marsh S
    Invest New Drugs; 2005 Dec; 23(6):533-7. PubMed ID: 16267625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the G>C SNP and rare mutations in the 28-bp repeat of TYMS using gel-based capillary electrophoresis.
    Thomas F; Hoskins JM; Dvorak A; Tan BR; McLeod HL
    Pharmacogenomics; 2010 Dec; 11(12):1751-6. PubMed ID: 21142919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis.
    Zhai X; Gao J; Hu Z; Tang J; Qin J; Wang S; Wang X; Jin G; Liu J; Chen W; Chen F; Wang X; Wei Q; Shen H
    BMC Cancer; 2006 May; 6():138. PubMed ID: 16723031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the TSER and G>C variants in the
    Favela-Mendoza AF; Godínez-López AD; Chávez-Arreguin M; Aguilar-Velázquez JA; Martínez-Cortes G; Rangel-Villalobos H
    Ann Hum Biol; 2023 Feb; 50(1):94-99. PubMed ID: 36789646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.
    Adleff V; Hitre E; Köves I; Orosz Z; Hajnal A; Kralovánszky J
    Int J Cancer; 2004 Mar; 108(6):852-6. PubMed ID: 14712487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TYMS and DPYD polymorphisms in a Turkish population.
    Süzen HS; Yüce N; Güvenç G; Duydu Y; Erke T
    Eur J Clin Pharmacol; 2005 Dec; 61(12):881-5. PubMed ID: 16328315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
    Mauritz R; Giovannetti E; Beumer IJ; Smid K; Van Groeningen CJ; Pinedo HM; Peters GJ
    Clin Colorectal Cancer; 2009 Jul; 8(3):146-54. PubMed ID: 19632929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T) and thymidylate synthase (TSER and TS 1494del6) polymorphisms with premature ovarian failure in Korean women.
    Rah H; Jeon YJ; Choi Y; Shim SH; Yoon TK; Choi DH; Cha SH; Kim NK
    Menopause; 2012 Nov; 19(11):1260-6. PubMed ID: 22713864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity.
    Cho HJ; Park YS; Kang WK; Kim JW; Lee SY
    Ther Drug Monit; 2007 Apr; 29(2):190-6. PubMed ID: 17417073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase enhancer region: Novel allele in Indians.
    Dhawan D; Padh H
    Ann Hum Biol; 2017 Feb; 44(1):87-90. PubMed ID: 27009482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer.
    Shi Q; Zhang Z; Neumann AS; Li G; Spitz MR; Wei Q
    Carcinogenesis; 2005 Mar; 26(3):649-56. PubMed ID: 15579479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer.
    Marsh S; McKay JA; Cassidy J; McLeod HL
    Int J Oncol; 2001 Aug; 19(2):383-6. PubMed ID: 11445856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidylate synthase gene variants as predictors of clinical response and toxicity to fluoropyrimidine-based chemotherapy for colorectal cancer.
    Castro-Rojas CA; Esparza-Mota AR; Hernandez-Cabrera F; Romero-Diaz VJ; Gonzalez-Guerrero JF; Maldonado-Garza H; Garcia-Gonzalez IS; Buenaventura-Cisneros S; Sanchez-Lopez JY; Ortiz-Lopez R; Camacho-Morales A; Barboza-Quintana O; Rojas-Martinez A
    Drug Metab Pers Ther; 2017 Dec; 32(4):209-218. PubMed ID: 29257755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis.
    Lopomo A; Ricciardi R; De Rosa A; Guida M; Maestri M; Lucchi M; Melfi F; Mussi A; Migliore L; Coppedè F
    Gene; 2018 Feb; 642():376-380. PubMed ID: 29162511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic tandem repeat sequences of the thymidylate synthase gene correlates with cellular-based sensitivity to fluoropyrimidine antitumor agents.
    Yawata A; Kim SR; Miyajima A; Kubo T; Ishida S; Saito Y; Nakajima Y; Katori N; Matsumoto Y; Fukuoka M; Ohno Y; Ozawa S; Sawada J
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):465-72. PubMed ID: 15918040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Berrevoets M; den Hoed MAH; Zolk O; Hoerning S; Pluijm SMF; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
    Pharmacogenet Genomics; 2018 Oct; 28(10):223-229. PubMed ID: 30222710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
    Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-dependent association of
    Ioannou C; Ragia G; Balgkouranidou I; Xenidis N; Amarantidis K; Koukaki T; Biziota E; Kakolyris S; Manolopoulos VG
    Pharmacogenomics; 2021 Jul; 22(11):669-680. PubMed ID: 34100299
    [No Abstract]   [Full Text] [Related]  

  • 20. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel.
    Nief N; Le Morvan V; Robert J
    Eur J Cancer; 2007 Mar; 43(5):955-62. PubMed ID: 17317154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.